Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
9
×
startups
9
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
cancer
alzheimer's disease
cancer immunotherapy
clinical trials
deals
eli lilly
fda
merck
astrazeneca
biogen
gilead sciences
What
bio
roundup
drug
companies
acquisitions
ceo
week
biggest
company
daniel
debut
gilead
moves
nash
new
news
o’day
sciences
therapeutics
years
according
addition
albert
alzheimer’s
announced
annual
apple
approval
approved
apps
assessed
attention
based
biogen’s
biopharmaceutical
biotech
black
bourla
bracelets
build
Language
unset
unknown
Current search:
abbvie
×
startups
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@techcrunch.com
4 years ago
What top VCs look for in women’s fertility startups
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@geekwire.com
5 years ago
Seattle startup Rodeo Therapeutics raises more cash for regenerative medicine treatments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More